Long-term excess mortality associated with diabetes following acute myocardial infarction: A population-based cohort study

Journal of Epidemiology and Community Health

Volumn 71, Issue 1, 2016, Pages 25-32

  Alabas, O A ^a   Hall, M ^a   Dondo, T B ^a   Rutherford, M J ^b   Timmis, A D ^c   Batin, P D ^d   Deanfield, J E ^e   Hemingway, H ^e   Gale, C P ^a,f  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE STRUCTURE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETES; HEALTH RISK; HEALTH STATUS; HEALTH SURVEY; MORBIDITY; MORTALITY; RISK FACTOR; SEX RATIO; SURVIVAL;

ENGLAND; UNITED KINGDOM; WALES;

AGED; DIABETES MELLITUS; ENGLAND; EPIDEMIOLOGY; FEMALE; HEART INFARCTION; HUMAN; MALE; MORTALITY; REGISTER; RISK FACTOR; SURVIVAL ANALYSIS; WALES;

AGED; DIABETES MELLITUS; ENGLAND; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; WALES;

EID: 85011785098     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2016-207402     Document Type: Article

References (26)

1. Norhammar A, Lindbäck J, Rydén L, et al. Improved but still high short-and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart 2007;93:1577-83.
2. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-900.
3. Gale CP, Cattle BA, Woolston A, et al. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. Eur Heart J 2012;33:630-9.
4. Spoon DB, Psaltis PJ, Singh M, et al. Trends in cause of death after percutaneous coronary intervention. Circulation 2014;129:1286-94.
5. Pedersen F, Butrymovich V, Kelbaek H, et al. Short-and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol 2014;64:2101-8.
6. Patel PA, Cubbon RM, Sapsford RJ, et al. An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction. Int J Cardiol 2016;203:141-4.
7. Jhund PS, McMurray JJ, Chaturvedi N, et al. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J 2015;36:2463-9.
8. Cubbon RM, Wheatcroft SB, Grant PJ, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over. 3000 patients between 1995 and 2003. Eur Heart J 2007;28:540-5.
9. Brophy S, Cooksey R, Gravenor MB, et al. Population based absolute and relative survival to 1 year of people with diabetes following a myocardial infarction: a cohort study using hospital admissions data. BMC Public Health 2010;10:338.
10. Schaffar R, Rachet B, Belot A, et al. Cause-specific or relative survival setting to estimate population-based net survival from cancer? An empirical evaluation using women diagnosed with breast cancer in Geneva between 1981 and 1991 and followed for 20 years after diagnosis. Cancer Epidemiol 2015;39:465-72.
11. Simms AD, Weston CF, West RM, et al. Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: a national cohort study. Eur Heart J Acute Cardiovasc Care 2015;4:241-53.
12. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
13. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
14. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
15. Hall M, Alabas O, Dondo TB, et al. Use of relative survival to evaluate non ST-elevation myocardial infarction quality of care and clinical outcomes. Eur Heart J 2015-Quality of Care and Clinical Outcomes 1:85-9.
16. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175-97.
17. Nelson CP, Lambert PC, Squire IB, et al. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med 2007;26:5486-98.
18. Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004;23:51-64.
19. Cattle BA, Baxter PD, Greenwood DC, et al. Multiple imputation for completion of a national clinical audit dataset. Stat Med 2011;30:2736-53.
20. Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1. 9 million people. Lancet Diabetes Endocrinol 2015;3:105-13.
21. Ahmed B, Davis HT, Laskey WK. In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010. J Am Heart Assoc 2014;3:pii: e001090.
22. Gandhi GY, Roger VL, Bailey KR, et al. Temporal trends in prevalence of diabetes mellitus in a population-based cohort of incident myocardial infarction and impact of diabetes on survival. Mayo Clin Proc 2006;81:1034-40.
23. Maier C, Mustapic D, Schuster E, et al. Effect of a pocket-size tablet-dispensing device on glycaemic control in Type 2 diabetic patients. Diabet Med 2006;23:40-5.
24. Cubbon RM, Adams B, Rajwani A, et al. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology. Diab Vasc Dis Res 2013;10:330-6.
25. West RM, Cattle BA, Bouyssie M, et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J 2011;32:706-11.
26. Grafféo N, Jooste V, Giorgi R. The impact of additional life-table variables on excess mortality estimates. Stat Med 2012;31:4219-30.